Teladoc Health, Inc. Cash Flow Statement
TDOC / Health Care|13 years of annual SEC 10-K data (FY2013-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 13 fiscal years. All figures from audited SEC 10-K filings.
Teladoc Health, Inc. generated $294M in operating cash flow and $285M in free cash flow in FY2025. Free cash flow margin was 11.3% of revenue.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -3.70 (distress zone, below 1.8 threshold)
- Negative profit margin: -8.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$200.3M | -$1.0B | -$220.4M | -$13.7B | -$428.8M | -$485.1M | -$98.9M | -$97.1M | -$106.8M | -$74.2M | -$58.0M | -$17.0M | -$6.0M |
| Depreciation & Amortization | - | - | - | $256.0M | $204.2M | $69.5M | $39.0M | $35.6M | $19.1M | $8.3M | $4.9M | $2.3M | $754.0K |
| Operating Cash Flow | $294.4M | $293.7M | $350.0M | $189.3M | $194.0M | -$53.5M | $29.9M | -$4.9M | -$34.4M | -$51.9M | -$47.2M | -$11.4M | -$6.1M |
| Capital Expenditures | $8.9M | $10.8M | $11.5M | $16.5M | $8.5M | $4.0M | $3.5M | $4.0M | $2.6M | $2.1M | $6.3M | $1.1M | $204.0K |
| Free Cash Flow | $285.5M | $282.9M | $338.6M | $172.8M | $185.5M | -$57.5M | $26.4M | -$8.9M | -$37.1M | -$54.0M | -$53.5M | -$12.4M | -$6.3M |
| Share Buybacks | - | - | - | - | - | - | - | - | - | - | - | $368.0K | $71.0K |
| FCF Margin | 11.3% | 11.0% | 13.0% | 7.2% | 9.1% | -5.3% | - | -2.1% | -15.9% | -43.8% | -69.1% | -28.5% | -31.4% |